Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2009
10/27/2009CA2365204C Lipoxin compounds and their use
10/27/2009CA2349529C Pge synthase and methods and means for modulating its activity
10/27/2009CA2318145C Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
10/22/2009WO2009129531A2 Bupivacaine formulation in a polyorthoester carrier
10/22/2009WO2009129511A2 Fluocinolone formulations in a biodegradable polymer carrier
10/22/2009WO2009129510A2 Sulindac formulations in a biodegradable material
10/22/2009WO2009129509A2 Methods and compositions for treating post-operative pain comprising a local anesthetic
10/22/2009WO2009129494A2 Alpha and beta adrenergic receptor agonists for treatment of pain and/or inflammation
10/22/2009WO2009129491A2 Beta adrenergic receptor agonists for treatment of pain and/or inflammation
10/22/2009WO2009129464A2 Method for treating acute pain with a formulated drug depot in combination with a liquid formulation
10/22/2009WO2009129456A2 Alpha adrenergic receptor agonists for treatment of inflammatory diseases
10/22/2009WO2009129453A2 Clonidine formulation in a polyorthoester carrier
10/22/2009WO2009129433A2 Alpha adrenergic receptor agonists for treatment of degenerative disc disease
10/22/2009WO2009129408A2 Compositions and methods for treating pathologic angiogenesis and vascular permeability
10/22/2009WO2009129246A2 Compositions and methods for preparing and using same
10/22/2009WO2009129163A2 Biological markers and response to treatment for pain, inflammation, neuronal or vascular injury and methods of use
10/22/2009WO2009129155A2 Dexamethasone formulations in a biodegradable material
10/22/2009WO2009129149A2 Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
10/22/2009WO2009129147A2 Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
10/22/2009WO2009129145A2 Sulfasalazine formulations in a biodegradable polymer carrier
10/22/2009WO2009128558A1 Activator for peroxisome proliferator-activated receptor
10/22/2009WO2009128543A1 Process for producing silica-containing tablet, tablet, and composite particle for tablet
10/22/2009WO2009128521A1 Cysteine protease inhibitor
10/22/2009WO2009128520A1 Heterocyclic compound having inhibitory activity on p13k
10/22/2009WO2009128481A1 Nitrogenated 5-membered heterocyclic compound
10/22/2009WO2009128395A1 Bone formation promoter comprising 2-aminophenol or derivative thereof as active ingredient
10/22/2009WO2009127949A1 4- [3- (aryloxy) benzylidene] -3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127948A1 4- [3- (aryloxy) benzylidene] -3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127946A1 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127944A1 Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127943A1 Ether benzylidene piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127320A1 Tertiary amine derivatives as phosphodiesterase-4 inhibitors
10/22/2009WO2009084975A8 Composition exhibiting high osmotic antimicrobial, anti-inflammatory and regeneration activity
10/22/2009WO2009073192A3 Systems and methods for delivery of materials
10/22/2009US20090265798 Desaturase genes and uses thereof
10/22/2009US20090264624 Human cytokine receptor
10/22/2009US20090264531 Sulindac formulations in a biodegradable material
10/22/2009US20090264530 Combined nsaid and acetaminophen formulation and method
10/22/2009US20090264515 Polynucleotide therapy
10/22/2009US20090264501 Methods and Compositions to Inhibit P2x7 Receptor Expression
10/22/2009US20090264484 Methods and Medicaments for Administration of Ibuprofen
10/22/2009US20090264478 Sulfasalazine formulations in a biodegradable polymer carrier
10/22/2009US20090264477 Beta adrenergic receptor agonists for treatment of pain and/or inflammation
10/22/2009US20090264469 Novel dicarboxylic acid derivatives
10/22/2009US20090264468 Methods for treating a disease in which Rho kinase is involved
10/22/2009US20090264454 Combined hydrocodone and analgesic formulation and method
10/22/2009US20090264452 2-(Phenylamino)-Pyrimidin-5-Amides As Cannabinoid 2 Receptors Modulators for the Treatment of Immune or Inflammatory Disorders
10/22/2009US20090264451 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
10/22/2009US20090264446 Condensed Pyridines as Kinase Inhibitors
10/22/2009US20090264427 3-Cyanoquinolines, Methods for Preparation and Use as Insulin-like Growth Factor Inhibitors
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090264422 Method of treating disease states using substituted pyrazole compounds
10/22/2009US20090264393 Nitrooxy derivatives of glucocorticoids
10/22/2009US20090264380 6,11-bridged biaryl macrolides
10/22/2009US20090264364 Genes implicated in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications
10/22/2009US20090264353 Splice Switching Oligomers for TNF Superfamily Receptors and their Use in Treatment of Disease
10/22/2009US20090264339 Heterocyclic Compounds
10/22/2009US20090263916 Antagonists of HMG1 for treating inflammatory conditions
10/22/2009US20090263498 Pharmaceutical preparations for treating inflammatory diseases
10/22/2009US20090263489 Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
10/22/2009US20090263486 Nanoparticle-stabilized capsule formulation for treatment of inflammation
10/22/2009US20090263474 Methods for Treating Autoimmune Diseases in a Subject and In Vitro Diagnostic Assays
10/22/2009US20090263466 Herbal composition for treatment of hyperlipidemia and the inhibition of myocardial infarction
10/22/2009US20090263463 Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
10/22/2009US20090263454 Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
10/22/2009US20090263450 Alpha adrenergic receptor agonists for treatment of inflammatory diseases
10/22/2009US20090263444 Fluocinolone Formulations in a Biodegradable Polymer Carrier
10/22/2009US20090263426 Methods for treating headache
10/22/2009US20090263404 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor
10/22/2009US20090263401 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE
10/22/2009US20090263335 Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
10/22/2009US20090263320 Peptide-Based Compounds
10/22/2009CA2721453A1 Sparc anti-inflammatory activity and uses thereof
10/22/2009CA2721339A1 Activating agent for peroxisome proliferator activated receptor
10/22/2009CA2721240A1 Tertiary amine derivatives as phosphodiesterase-4 inhibitors
10/22/2009CA2720990A1 Alpha and beta adrenergic receptor agonists for treatment of pain and/or inflammation
10/22/2009CA2720671A1 Compositions and methods for preparing and using same
10/22/2009CA2720670A1 Biological markers and response to treatment for pain, inflammation, neuronal or vascular injury and methods of use
10/22/2009CA2719789A1 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009CA2719785A1 Ether benzylidene piperidine aryl carboxamide compounds
10/22/2009CA2719784A1 Ether benzylidene piperidine 5-membered aryl carboxamide compounds
10/22/2009CA2717087A1 4-[3-(aryloxy)benzylidene]-3-methyl piperidine 5-membered aryl carboxamides
10/22/2009CA2700736A1 Methods and compositions for treating post-operative pain comprising a local anesthetic
10/22/2009CA2700578A1 Alpha adrenergic receptor agonists for treatment of inflammatory diseases
10/22/2009CA2700196A1 Method for treating acute pain with a formulated drug depot in combination with a liquid formulation
10/22/2009CA2693001A1 Compositions and methods for treating pathologic angiogenesis and vascular permeability
10/21/2009EP2110375A1 Phosphodiesterase-4 inhibitors belonging to the tertiary amine class
10/21/2009EP2110142A2 Inhibition of secretion from non-neuronal cells
10/21/2009EP2110134A1 Cocoa extract compounds and methods for making and using the same
10/21/2009EP2110132A1 Use of deuterium oxide as elastase inhibitor
10/21/2009EP2109610A1 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors
10/21/2009EP2109608A1 Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
10/21/2009EP2109607A1 Pyrrolo[3, 2-a]pyridine derivatives for inhibiting ksp kinesin activity
10/21/2009EP1513531B1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
10/21/2009EP1450750B1 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
10/21/2009EP1423413B1 Peptidic compounds selectively binding to p-selectin
10/21/2009EP1415154B1 Control of growth and repair of gastro-intestinal tissues by gastrokines
10/21/2009EP1383778B1 Agonists and antagonists of sphingosine-1-phosphate receptors
10/21/2009EP1280776B1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
10/21/2009EP1207877B1 Anti-inflammatory actions of cytochrome p450 epoxygenase-derived eicosanoids
1 ... 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 ... 1272